Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cisplatin (platinol) (1 trial)
doxorubicin (Doxil) (1 trial)
l-dos47 (4 trials)
vinorelbine (navelbine) (1 trial)
Adenocarcinoma (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (4 total)